85 related articles for article (PubMed ID: 8617312)
1. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses.
Ozdemirli M; El-Khatib M; Foote LC; Wang JK; Marshak-Rothstein A; Rothstein TL; Ju ST
Eur J Immunol; 1996 Feb; 26(2):415-9. PubMed ID: 8617312
[TBL] [Abstract][Full Text] [Related]
2. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
3. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
Majlessi L; Bordenave G
J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
[TBL] [Abstract][Full Text] [Related]
4. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
Stohl W; Elliott JE; Lynch DH; Kiener PA
J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
6. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
Whalen BJ; Tony HP; Parker DC
J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
Rogers AM; Thilenius AR; Russell JH
J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of Fas antigen on activated murine B cells.
Wang J; Taniuchi I; Maekawa Y; Howard M; Cooper MD; Watanabe T
Eur J Immunol; 1996 Jan; 26(1):92-6. PubMed ID: 8566089
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of FasL-mediated cytotoxicity by CD4+ Th1 clones.
el-Khatib M; Stanger BZ; Dogan H; Cui H; Ju ST
Cell Immunol; 1995 Jul; 163(2):237-44. PubMed ID: 7541726
[TBL] [Abstract][Full Text] [Related]
12. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
Noble A; Pestano GA; Cantor H
J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
[TBL] [Abstract][Full Text] [Related]
13. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
14. Activated B cells express functional Fas ligand.
Hahne M; Renno T; Schroeter M; Irmler M; French L; Bornard T; MacDonald HR; Tschopp J
Eur J Immunol; 1996 Mar; 26(3):721-4. PubMed ID: 8605944
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
16. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.
Rothstein TL; Wang JK; Panka DJ; Foote LC; Wang Z; Stanger B; Cui H; Ju ST; Marshak-Rothstein A
Nature; 1995 Mar; 374(6518):163-5. PubMed ID: 7533263
[TBL] [Abstract][Full Text] [Related]
17. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells.
Poudrier J; Owens T
Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727
[TBL] [Abstract][Full Text] [Related]
18. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
Stohl W; Lynch DH; Starling GC; Kiener PA
J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
[TBL] [Abstract][Full Text] [Related]
19. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
Stohl W; Xu D; Starling GC; Casali P; Kiener PA
Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
[TBL] [Abstract][Full Text] [Related]
20. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
